ArticleOpen forum infectious diseases2022

Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass Resistance.

Ellen H Nagami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.